The European Academy for Cognitive Behavioural Therapy for Insomnia: An initiative of the European Insomnia Network to promote implementation and dissemination of treatment

Chiara Baglioni, Ellemarije Altena, Bjørn Bjorvatn, Kerstin Blom, Kristoffer Bothelius, Alessandra Devoto, Colin A. Espie, Lukas Frase, Dimitri Gavriloff, Hion Tuuliki, Andrea Hoflehner, Birgit Högl, Brigitte Holzinger, Heli Järnefelt, Susanna Jernelöv, Anna F. Johann, Caterina Lombardo, Christoph Nissen, Laura Palagini, Geert Peeters, Michael L. Perlis, Donn Posner, Angelika Schlarb, Kai Spiegelhalder, Adam Wichniak, Dieter Riemann
J Sleep Res. 2019-12-19; :
DOI: 10.1111/jsr.12967

Lire sur PubMed

Baglioni C(1)(2), Altena E(3), Bjorvatn B(4), Blom K(5), Bothelius K(6), Devoto A(7), Espie CA(8), Frase L(1), Gavriloff D(8), Tuuliki H(9)(10), Hoflehner A(11), Högl B(11), Holzinger B(12), Järnefelt H(13)(14), Jernelöv S(5)(15), Johann AF(1)(16), Lombardo C(17), Nissen C(18), Palagini L(19), Peeters G(20), Perlis ML(21), Posner D(22), Schlarb A(23), Spiegelhalder K(1), Wichniak A(24), Riemann D(1).

Author information:
(1)Department of Psychiatry and Psychotherapy, Faculty of Medicine, Medical Center – University of Freiburg, University of Freiburg, Freiburg, Germany.
(2)Department of Human Sciences, University of Rome ‘G. Marconi’ – Telematic, Rome, Italy.
(3)UMR 5287, Institut de Neurosciences Intégratives et Cognitives d’Aquitaine, Neuroimagerie et Cognition Humaine, CNRS, Université de Bordeaux, Bordeaux, France.
(4)Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
(5)Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, and Stockholm Health Care Services, Stockholm County Council, Huddinge Hospital, Stockholm, Sweden.
(6)Department of Psychology, Uppsala University, Uppsala, Sweden.
(7)Centre for Sleep Medicine, Rome, Italy.
(8)Nuffield Department of Clinical Neuroscience, Sleep and Circadian Neuroscience Institute, University of Oxford, Oxford, UK.
(9)Nordic Sleep Centre, Tallinn, Estonia.
(10)Tartu University Hospital, Tartu, Estonia.
(11)Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
(12)Institut für Bewusstseins- und Traumforschung, Wien, Austria.
(13)Finnish Institute of Occupational Health, Helsinki, Finland.
(14)Department of Psychology and Logopedics, University of Helsinki, Finland.
(15)Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Sweden.
(16)Medical Psychology and Medical Sociology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
(17)Department of Psychology, « Sapienza » University of Rome, Rome, Italy.
(18)University Hospital of Psychiatry and Psychotherapy, Bern, Switzerland.
(19)Department of Neuroscience, University of Pisa, Pisa, Italy.
(20)Sleep Medicine Centre Kempenhaeghe, Heeze, The Netherlands.
(21)Department of Psychiatry, Upenn Behavioral Sleep Medicine Program, University of Pennsylvania, Philadelphia, PA, USA.
(22)Stanford University School of Medicine, Stanford, CA, USA.
(23)Department of Psychology, University of Bielefeld, Bielefeld, Germany.
(24)Sleep Medicine Centre and Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland.

Insomnia, the most prevalent sleep disorder worldwide, confers marked risks for both physical and mental health. Furthermore, insomnia is associated with considerable direct and indirect healthcare costs. Recent guidelines in the US
and Europe unequivocally conclude that cognitive behavioural therapy for insomnia (CBT-I) should be the first-line treatment for the disorder. Current treatment approaches are in stark contrast to these clear recommendations, not least across Europe, where, if any treatment at all is delivered, hypnotic medication still is the dominant therapeutic modality. To address this situation, a Task Force of the European Sleep Research Society and the European Insomnia Network met in May
2018. The Task Force proposed establishing a European CBT-I Academy that would enable a Europe-wide system of standardized CBT-I training and training centre accreditation. This article summarizes the deliberations of the Task Force
concerning definition and ingredients of CBT-I, preconditions for health professionals to teach CBT-I, the way in which CBT-I should be taught, who should be taught CBT-I and to whom CBT-I should be administered. Furthermore, diverse aspects of CBT-I care and delivery were discussed and incorporated into a stepped-care model for insomnia.

© 2019 The Authors. Journal of Sleep Research published by John Wiley & Sons Ltd on behalf of European Sleep Research Society.


Auteurs Bordeaux Neurocampus